Frédéric Lemay

Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer

Thierry Conroy, Florence Castan, Anthony Lopez et al. · JAMA Oncology · 2022 · 324 citations · Full text

Medicine, Oncology, Surgery +14

The CCTG PA.7 phase II trial of gemcitabine and nab-paclitaxel with or without durvalumab and tremelimumab as initial therapy in metastatic pancreatic ductal adenocarcinoma

Daniel J. Renouf, Jonathan M. Loree, Jennifer J. Knox et al. · Nature Communications · 2022 · 139 citations · Full text

Medicine, Oncology, Pharmacology +17

Estrogen receptor β deficiency enhances small intestinal tumorigenesis in <i>Apc</i>^Min/+ mice

Véronique Giroux, Frédéric Lemay, Gérald Bernatchez et al. · International Journal of Cancer · 2008 · 80 citations · Full text

Medicine, Endocrinology, Oncology +15

Many-body theory versus simulations for the pseudogap in the Hubbard model

S. Moukouri, S. Allen, Frédéric Lemay et al. · Physical review. B, Condensed matter · 2000 · 78 citations · Full text

Natural Sciences, Physics, Condensed Matter Physics +15

Combined HER2 analysis of biopsies and surgical specimens to optimize detection of trastuzumab-eligible patients in eso-gastric adenocarcinoma: a GERCOR study

Sarah Watson, Pierre Validire, Pascale Cervera et al. · Annals of Oncology · 2013 · 43 citations

Medicine, Oncology, Pathology +15